Determining cost-saving risk thresholds for statin use.

ABSTRACT:

Background

The German government has recently drafted a bill proposing a reduction in the prescription threshold for statin use. This study aims to determine the cost-saving risk threshold for statin use in Germany to inform this proposed change.

Methods

An economic evaluation utilizing a decision-analytic model was performed, using secondary data to compare statin use versus no statin use from the perspective of German sickness fund insurees. The analysis focused on cost savings from avoided cardiovascular (CV) events, translating these avoided events into net savings after accounting for treatment costs and potential side effects. The study considered the German adult population insured by sickness funds and used a lifetime horizon for the analysis.

Results

The maxi

SUBMITTER: Gandjour A 

PROVIDER: S-EPMC11906068 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature